Featured Research

from universities, journals, and other organizations

Safety Guide Launched For New 3-D Dental Scans

Date:
February 5, 2009
Source:
University of Manchester
Summary:
Important new guidelines for dentists using the latest three-dimensional imaging system in their surgeries have been established for UK and European practitioners.

Important new guidelines for dentists using the latest three-dimensional imaging system in their surgeries have been established for UK and European practitioners.

Cone Beam Computed Tomography (CBCT), which gives a similar kind of image as a medical CT scan, is now available in high-street dental practices to give high-definition, three-dimensional scans of patients’ jaws and teeth.

However, CBCT carries an increased risk associated with greater radiation dose than traditional dental X-rays, so the European Academy of Dental and Maxillofacial Radiology (EADMFR) has developed 20 ‘Basic Principles’ for use of CBCT in dentistry.

The guidelines, which establish the safe and ethical use of CBCT, have been drawn up by the EADMFR in collaboration with the EU-funded SEDENTEXCT project, which was set up to conduct research into the use of CBCT in dentistry.

“In many European countries, dentists can purchase and use CBCT without any additional training and so there was a pressing need to establish some guidelines,” explained SEDENTEXCT coordinator Professor Keith Horner, who is based at The University of Manchester.

“The 20 Basic Principles are aimed at protecting the patient and guiding the dentist towards good practice covering important areas such as justification and optimisation of CBCT examinations and training of users.”

Among the Basic Principles are guidelines about when CBCT examinations may be justified, as well information about training, equipment and safety measures.

Dr Lennart Flygare, EADMFR President, said: “We hope that this document will be a core standard within Europe for dentists, dental specialists and equipment manufacturers.”


Story Source:

The above story is based on materials provided by University of Manchester. Note: Materials may be edited for content and length.


Cite This Page:

University of Manchester. "Safety Guide Launched For New 3-D Dental Scans." ScienceDaily. ScienceDaily, 5 February 2009. <www.sciencedaily.com/releases/2009/02/090205083707.htm>.
University of Manchester. (2009, February 5). Safety Guide Launched For New 3-D Dental Scans. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/02/090205083707.htm
University of Manchester. "Safety Guide Launched For New 3-D Dental Scans." ScienceDaily. www.sciencedaily.com/releases/2009/02/090205083707.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins